Ipsen

China - TianjinBiotechnology1 H-1B visas (FY2023)

Focus: Ipsen is a mid-size biopharmaceutical company headquartered in Tianjin, China, with 1,001–5,000 employees specializing in small molecules and biologics across oncology, endocrinology, neurology, and gastroenterology. The company generates 73% of revenue from its flagship product AURYXIA (ferric citrate), indicating heavy reliance on a single asset.

Oncology Endocrinology Neurology Gastroenterology

Profile data last refreshed 7h ago · AI intelligence enriched 2w ago

Employees

1001-5000

Open Jobs

About Ipsen

AI assessmentNot Hiring

No open roles listed right now. Follow Ipsen to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

5/9 — Partial

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

1 in 5yr

AURYXIA

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

AURYXIA

Iron Deficiency Anemia in Chronic Kidney Disease Not on Dialysis; phosphate binder

$183M Part D

Peak

Help build intelligence for Ipsen

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Exposure to multiple therapeutic areas (oncology, endocrinology, neurology, gastroenterology, metabolic diseases) with a portfolio spanning small molecules and biologics.
Growing pipeline momentum, evidenced by recent Phase III wins in migraine with Dysport (announced July 2026) and ongoing Phase 3 studies in oncology, liver disease, and rare disorders.
Established market position with a peak-stage franchise (AURYXIA at $183M Part D spending) and long-dated LOE horizons (AURYXIA until 2030, several Phase 3 programs extending runway).

Pipeline & Clinical Trials

Somatuline Autogel® 60, 90 or 120 mg

Acromegaly

N/A

Clinical Trials (1)

NCT01840449Somatuline Predictive Factors in Acromegaly and NET

N/A

platinum chemotherapy

Neuroendocrine Tumors

N/A

Clinical Trials (1)

NCT04365023Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

N/A

Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromega

Acromegaly

N/A

Clinical Trials (1)

NCT05184231Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

N/A

Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients

Cervical Dystonia

N/A

Clinical Trials (1)

NCT01840462Longitudinal Study for Treatment With Botulinum Toxin A Injections in naïve and Pre-treated Patients Suffering From Cervical Dystonia [CD-NIS-Longterm]

N/A

Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or M

Advanced Renal Cell Carcinoma

N/A

Clinical Trials (1)

NCT03647878Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.

N/A

This is a non-interventional study. Patients will be treated with any intervention deemed appropriate by the patient's physician.

Gastroenteropancreatic Neuroendocrine Tumors

N/A

Clinical Trials (1)

NCT02630654Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs

N/A

Botulinum toxin type A

Lower Limb Spasticity

N/A

Clinical Trials (1)

NCT02020980RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke

N/A

Data collection

Ulcerative Colitis

N/A

Clinical Trials (1)

NCT03689673Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC)

N/A

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for H

Neuroendocrine Tumors

N/A

Clinical Trials (1)

NCT01234168A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

N/A

To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Follo

Muscle Spasticity

N/A

Clinical Trials (1)

NCT01020500To Document the Effectiveness of BoNT-A Injection in Adult Subjects With Upper Limb Spasticity Following Stroke

N/A

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptor

Prostate Cancer

N/A

Clinical Trials (1)

NCT04593420Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

N/A

Lanreotide

Polycystic Liver Disease

N/A

Clinical Trials (1)

NCT01354405Somatostatin Analogues as a Volume Reducing Treatment of Polycystic Livers (RESOLVE)

N/A

Epithelioid Sarcoma Natural History Study

Epithelioid Sarcoma

N/A

Clinical Trials (1)

NCT03837678Epithelioid Sarcoma Natural History Study

N/A

Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real

Upper Limb Spasticity

N/A

Clinical Trials (1)

NCT02454803Attainment of Person-centred Goals After Botulinum Toxin Treatment for Upper Limb Spasticity in Real Life Practice

N/A

Diagnosis of acromegaly

Sleep Apnea Syndrome

N/A

Clinical Trials (1)

NCT02789696Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome

N/A

Description of Sign-and-symptom Associations at Acromegaly Diagnosis.

Acromegaly

N/A

Clinical Trials (1)

NCT02012127Description of Sign-and-symptom Associations at Acromegaly Diagnosis.

N/A

A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, Grip

Upper Limb Spasticity (ULS)

N/A

Clinical Trials (1)

NCT05169775A Single Centre, Prospective, Observational Study to Assess the Use of the Rehabilitation Tool, GripAble, in Patients With Upper Limb Spasticity Receiving Botulinum Toxin-A (BoNT-A) in the United Kingdom (UK).

N/A

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

Renal Cell Carcinoma

N/A

Clinical Trials (1)

NCT03776123Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

N/A

A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrah

PFIC - Progressive Familial Intrahepatic Cholestasis

N/A

Clinical Trials (1)

NCT07191704A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain

N/A

A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GE

Gastro-enteropancreatic Neuroendocrine Tumor

N/A

Clinical Trials (1)

NCT06253897A Study to Understand Participant's Experiences in Gastro-enteropancreatic Neuroendocrine Tumors (GEP-NETs) and Acromegaly

N/A

Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documenta

Post-stroke Arm Spasticity

N/A

Clinical Trials (1)

NCT01840475Arm Spasticity - Non-Interventional Study Early BIRD (BoNT Treatment: Initial and Repeated Documentation)

N/A

Validation of Patient Reported Outcome Measures for Use in Vulvodynia

Vulvodynia

N/A

Clinical Trials (1)

NCT03770169Validation of Patient Reported Outcome Measures for Use in Vulvodynia

N/A

Data collection

Neurologic Disorder

N/A

Clinical Trials (1)

NCT03329872Neuro-Orthopedic Registry of the University Hospital of Toulouse

N/A

Surgical resection

Adenocarcinoma of the Pancreas

N/A

Clinical Trials (1)

NCT07340151Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

N/A

EGb761®

Cognitive Disorders

N/A

Clinical Trials (1)

NCT02321475EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders

N/A

Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cer

Idiopathic Cervical Dystonia

N/A

Clinical Trials (1)

NCT00833196Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia

N/A

Bedside Referral Tool

Spasticity, Muscle

N/A

Clinical Trials (1)

NCT03209960Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity

N/A

A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

Growth Hormone Disorders

N/A

Clinical Trials (1)

NCT00455728A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders

N/A

National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)

Renal Cancer

N/A

A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

Fibrodysplasia Ossificans Progressiva

N/A

Clinical Trials (1)

NCT02322255A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)

N/A

Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botuli

Post-Stroke Chronic Upper Limb Spasticity

N/A

Clinical Trials (1)

NCT05224349Effectiveness and Safety of SMART [Spastic Muscle Palpation by Anatomic Landscape for BoNT-A (Botulinumtoxin-A) Injection to Reduce Muscle Tone] BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity (ULS) in Real-life Setting.

N/A

Data collection

Spasticity, Muscle

N/A

Clinical Trials (1)

NCT03442660Validation of the Spasticity Related Quality of Life Questionnaire

N/A

Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study

Acromegaly

N/A

Clinical Trials (1)

NCT00686348Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study

N/A

Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke

Upper Limb Spasticity Post-Stroke

N/A

Clinical Trials (1)

NCT02384330Botulinum Toxin A Associated Costs in the Treatment of Upper Limb Spasticity Post Stroke

N/A

Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real

Adult Lower Limb Spasticity

N/A

Clinical Trials (1)

NCT04050527Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

N/A

Adult Subjects Suffering From Lower Limb Spasticity Following Stroke

Spasticity

N/A

Clinical Trials (1)

NCT01444794Adult Subjects Suffering From Lower Limb Spasticity Following Stroke

N/A

A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Fam

Progressive Familial Intrahepatic Cholestasis

N/A

Clinical Trials (1)

NCT07185919A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

N/A

IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population

IGF-1 Deficiency

N/A

Clinical Trials (1)

NCT01676090IGF-1, IGFBP3, ALS Normative Ranges in Healthy Pediatric Spanish Population

N/A

Eziclen®/Izinova®

Bowel Cleansing

N/A

Clinical Trials (1)

NCT02630680Eziclen Drug Utilisation in Real Life Setting

N/A

Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In

Spasticity

N/A

Clinical Trials (1)

NCT04446702Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA

N/A

CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients

Upper Limb Injury

N/A

Clinical Trials (1)

NCT06245772CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity

N/A

Bimanual 3D Motion Analysis " Be-API "

Unilateral Spastic Cerebral Palsy

N/A

Clinical Trials (1)

NCT03888443"Be an Airplane Pilot": A Bimanual 3D Motion Analysis in Children With Unilateral Cerebral Palsy

N/A

Validation of Patient Reported Outcome Measures for Use in Hallux Valgus

Hallux Valgus

N/A

Clinical Trials (1)

NCT03846687Validation of Patient Reported Outcome Measures for Use in Hallux Valgus

N/A

Hexvix

Photodynamic Transurethral Resection of the Bladder (TUR-B)

N/A

Clinical Trials (1)

NCT02012036Study To Optimize Photodynamic Transurethral Resection of the Bladder (TUR-B) In Clinical Practice

N/A

A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to A

Spastic Hemiparesis

N/A

Clinical Trials (1)

NCT05546190A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)

N/A

An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progress

Fibrodysplasia Ossificans Progressiva

N/A

Clinical Trials (1)

NCT04665323An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.

N/A

Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulin

Spasticity

N/A

Clinical Trials (1)

NCT04340336Study Assessing Adult Subjects Affected With Upper and/or Lower Limb Spasticity Treated With Botulinum Neurotoxin Type A

N/A

Observational study

Kidney Neoplasms

N/A

Clinical Trials (1)

NCT05184504Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American

N/A

Drug-induced Liver Injury: Itching Study

Drug Induced Liver Injury

N/A

Clinical Trials (1)

NCT06446609Drug-induced Liver Injury: Itching Study

N/A

SAGIT

Acromegaly

N/A

Clinical Trials (1)

NCT02231593SAGIT for Classification of Patients With Acromegaly in Clinical Practice

N/A

Interview Prep Quick Facts

Founded: 1986

Portfolio: 11 approved products, 149 clinical trials

Top TAs: Oncology, Endocrinology, Neurology

H-1B (2023): 1 approval

Publications: 49 in PubMed

Portfolio Health

Growth1 (9%)

Peak4 (36%)

LOE Approaching3 (27%)

Post-LOE3 (27%)

11 total products

Therapeutic Area Focus

Oncology

4 marketed164 pipeline

Endocrinology

2 marketed42 pipeline

Neurology

1 marketed24 pipeline

Gastroenterology

1 marketed20 pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.

Global & regional health technology assessment

2026

PMID:42488499

Effect of an Integrated Postdischarge Care Program for Older Patients After Hip Fracture Discharged to the Community: A Multicenter Cohort Study.

Ipsen

About Ipsen

Why Work Here

Key Products

Watch Out For

Products & Portfolio (8)

Key Products by Revenue

Other Products (3)

Pipeline & Clinical Trials

Recent News · Ipsen(10)

Open Jobs (0)

Hiring Trend

Visa Sponsorship

Research Publications(10)